about
Hysteroscopy in the treatment of uterine cesarean section scar diverticulum: A systematic review.Coital incontinence: a factor for deteriorated health-related quality of life and sexual function in women with urodynamic stress urinary incontinence.Major complications following exenteration in cases of pelvic malignancy: a 10-year experience.Tumor heterogeneity at protein level as an independent prognostic factor in endometrial cancer.Mutational analysis of BRCA1/2 in a group of 134 consecutive ovarian cancer patients. Novel and recurrent BRCA1/2 alterations detected by next generation sequencing.Analysis of large mutations in BARD1 in patients with breast and/or ovarian cancer: the Polish population as an exampleAnalysis of the usage of continence pads and help-seeking behavior of women with stress urinary incontinence in Poland.Pregnancy and Delivery in Patients with Mastocytosis Treated at the Polish Center of the European Competence Network on Mastocytosis (ECNM).Deregulation of RAD21 and RUNX1 expression in endometrial cancer.HER2-positive endometrial cancer subtype carries poor prognosis.Predictors of sexual function in women with stress urinary incontinence."Niche" czyli ubytek w miejscu blizny mięśniówki macicy po cięciu cesarskim - przyczyny, diagnostyka, objawy.Conservative treatment of borderline ovarian tumors: the experience of one clinical center.Cancer predisposing BARD1 mutations affect exon skipping and are associated with overexpression of specific BARD1 isoforms.Complications associated with 9-10Fr venous access port use in adjuvant intraperitoneal chemotherapy after a cytoreductive surgery in ovarian cancer patients.Comparison of SPECT-CT results and intraoperative detection of sentinel lymph nodes in endometrial cancer.Polish translation and validation of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire, IUGA-Revised (PISQ-IR).Twenty-four-hour and conventional blood pressure components and risk of preterm delivery or neonatal complications in gestational hypertension.Validation of the Polish version of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire.Surgery course evaluation. Expectations of medical students in surgery rotation? From bench to bedside.[Micrometastases in sentinel lymph node in endometrial cancer patients].Sentinel Lymph Node Biopsy in Endometrial Cancer--Comparison of 2 Detection Methods.Emergency pelvic packing to control massive intraoperative bleeding during pelvic posterior exenteration.The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24.Laparoscopic supracervical hysterectomy with the use of the More-Cell-Safe system in a patient with uterine leiomyomas.A multimarker qPCR platform for the characterisation of endometrial cancer.Spectrum and Prevalence of Pathogenic Variants in Ovarian Cancer Susceptibility Genes in a Group of 333 PatientsMalignant melanoma of the uterine cervixA giant ovarian fibromaMultiple multiparity is a negative prognostic factor for endometrial cancer in PolandRak błony śluzowej trzonu macicy u chorych po przebytej chorobie nowotworowej - aspekty kliniczne i molekularneValidation of the Polish version of the Pelvic Floor Distress Inventory24/7 usage of continence pads and quality of life impairment in women with urinary incontinenceThe management of gynecological complications in long-term survivors after allogeneic hematopoietic cell transplantation-a single-center real-life experience
P50
Q30234477-CF6614CA-7CE0-4F5B-B48D-8C71EB810312Q33586210-B6133A83-6BCD-4419-87C4-FFB62FC5B693Q33868165-997801AB-DC3B-4958-A1C0-DF17BB92BA61Q34478381-91570EE3-F44C-466D-9C2A-EEF70D43FC67Q35546258-F49269BF-A47B-4D7B-8CA2-03C17D9CAAFEQ35631708-964ED38E-9E74-42E7-A710-7E496ED2755DQ35794119-8335535A-B615-43BE-8FD3-ACA1E54C4414Q35900583-35AA6FEF-14DA-4D64-81BC-BA4D82578C78Q36423904-297D172F-C2DB-4997-812F-D1BC8E3A42ADQ37700593-9B6232AA-4ECA-47D5-A420-1EFACA14492BQ38647033-627C2B03-414F-4D97-96AD-2D62C1E2B1CFQ38852720-650A7904-92CF-4B68-9192-A8290D236EE7Q40213583-81E09B0B-65C3-41B1-BCB7-D857DE2DA4ACQ40584544-7C7E5045-C055-4E37-821E-D6B91D8690B2Q41343143-42B47146-711A-448E-A6E2-33319CB454F5Q44286179-8D8B9A3D-541B-4D5F-8C18-4091FA496FE0Q47559157-4DAE1A3C-120E-491A-B341-B0ACDD0B69A0Q47847480-005B5701-C09A-4EC3-8887-645A922FBAEAQ47912374-4C86CF32-899B-4CB2-856F-45C3B6C18761Q48021489-9723D2A5-5FA7-44F6-A48F-97885BF13C19Q50212663-A19EDDBA-76E9-4A99-AFAA-7146588485FCQ50215665-463E2B87-29DA-41C2-8997-D37FE78B0C43Q51582117-176E9172-4CA9-4072-89F2-04D1173F45F8Q53226510-BE10BEFF-4506-4F86-897C-9D5CC7248B57Q54098890-20D7438C-489D-4B4A-8FC1-65E04F96F4C6Q54231742-65E664CC-AF93-4D76-88B5-4EE8A1BF7CACQ59806410-4CE3BBCD-3117-4B9B-84A9-DC6407F9DC8AQ81058381-23F869F1-286D-40A6-A73B-B8A94C1AE6A0Q83856847-079C27A3-3FE9-4EDA-9ABA-10D038841CABQ87675604-08B56E81-CC3B-44D3-B99C-012C302D3834Q87676077-2F7385D6-6F37-4609-A332-9393EB5F9FC5Q90018611-A857F351-1CA1-4AD6-964B-6D174ACB1D4BQ91534015-9A0B6B4C-ABF3-434E-B093-442650CA61DDQ93274226-05235EA8-5B18-4424-B4C9-3BD17FB96E4C
P50
description
researcher ORCID ID = 0000-0002-4510-9558
@en
wetenschapper
@nl
name
Dariusz Wydra
@ast
Dariusz Wydra
@ca
Dariusz Wydra
@cs
Dariusz Wydra
@en
Dariusz Wydra
@es
Dariusz Wydra
@gl
Dariusz Wydra
@hr
Dariusz Wydra
@hsb
Dariusz Wydra
@it
Dariusz Wydra
@nl
type
label
Dariusz Wydra
@ast
Dariusz Wydra
@ca
Dariusz Wydra
@cs
Dariusz Wydra
@en
Dariusz Wydra
@es
Dariusz Wydra
@gl
Dariusz Wydra
@hr
Dariusz Wydra
@hsb
Dariusz Wydra
@it
Dariusz Wydra
@nl
altLabel
Dariusz Grzegorz Wydra
@pl
prefLabel
Dariusz Wydra
@ast
Dariusz Wydra
@ca
Dariusz Wydra
@cs
Dariusz Wydra
@en
Dariusz Wydra
@es
Dariusz Wydra
@gl
Dariusz Wydra
@hr
Dariusz Wydra
@hsb
Dariusz Wydra
@it
Dariusz Wydra
@nl
P214
P1412
P1559
Dariusz Wydra
@pl
P21
P214
P27
P31
P3124
P496
0000-0002-4510-9558
P734
P7859
viaf-161525559